GleamWall
中文EN

HLYK HealthLynked Corp

Services-Offices & Clinics of Doctors of Medicine · OTC · SEC CIK 1680139 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-52.0%
TTM net income YoY-4.5%
TTM EPS YoY1.5%
Revenue 3-yr CAGR-43.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-202.3%
Net margin-351.6%
FCF margin—
EBITDA margin-196.7%

Returns

ROE—
ROA-234.0%
ROIC (approx.)—
Asset turnover0.67x

Leverage & solvency

Liabilities / assets641.2%
Debt / equity—
Current ratio0.52x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-153.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.07M$3.01M
SG&A expense$2.04M$3.04M
Operating income-$2.11M-$4.68M
Pretax income-$3.28M-$6.13M
Net income-$3.28M-$6.13M
EBITDA-$2.01M-$4.39M
EPS (basic)-1.16-2.18
EPS (diluted)-1.16-2.18
Weighted avg. shares (diluted)2.84M2.82M
Balance sheet
Cash & equivalents$37,136$76,241
Inventory$17,962$44,686
Current assets$1.55M$1.64M
PP&E, net$74,705$176,576
Total assets$1.70M$2.22M
Current liabilities$7.01M$4.69M
Total liabilities$7.46M$5.35M
Shareholders' equity-$5.76M-$3.13M
Shares outstanding2.88M2.82M
Cash flow statement
Operating cash flow-$1.71M-$3.49M
Capital expenditure—$2,598
Free cash flow—-$3.50M
Investing cash flow$125,000$422,402
Financing cash flow$1.55M$2.90M
Depreciation & amortization$101,871$282,950
Stock-based compensation$158,625$210,333

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.